Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N-(2,3-dichlorophenyl)triazolyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | IC50: 9 nM | Homo sapiens | |
N-(2-chlorophenyl)triazolyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | IC50: 6 nM | Homo sapiens | |
N-(5-isopropyl)pyridine-2-carboxyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | IC50: less than 3 nM | Homo sapiens | |
N-4-benzyloxybenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | IC50: 6 nM | Homo sapiens | |
N-4-isopropylbenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | IC50: less than 3 nM | Homo sapiens | |
N-4-methoxybenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | - |
Homo sapiens | |
N-4-propylbenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | IC50: less than 3 nM | Homo sapiens | |
Nalpha-3-chlorobenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | less efficient than Nalpha-benzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | Oryctolagus cuniculus | |
Nalpha-3-methoxybenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | less efficient than Nalpha-benzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | Oryctolagus cuniculus | |
Nalpha-3-methylbenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | - |
Oryctolagus cuniculus | |
Nalpha-4-chlorobenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | - |
Oryctolagus cuniculus | |
Nalpha-4-methoxybenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | IC50: 64 nM | Oryctolagus cuniculus | |
Nalpha-4-methylbenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | - |
Oryctolagus cuniculus | |
Nalpha-benzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | IC50: 470 nM | Oryctolagus cuniculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Oryctolagus cuniculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
osteoclast | - |
Homo sapiens | - |
osteoclast | - |
Oryctolagus cuniculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Z-Phe-Arg-4-methylcoumarin 7-amide + H2O | - |
Homo sapiens | Z-Phe-Arg + 7-amino-4-methylcoumarin | - |
? |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000011 | - |
N-(2,3-dichlorophenyl)triazolyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | standard assay conditions | Homo sapiens | |
0.000015 | - |
N-4-benzyloxybenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | standard assay conditions | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000003 | - |
IC50: less than 3 nM | Homo sapiens | N-4-propylbenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | |
0.000003 | - |
IC50: less than 3 nM | Homo sapiens | N-4-isopropylbenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | |
0.000003 | - |
IC50: less than 3 nM | Homo sapiens | N-(5-isopropyl)pyridine-2-carboxyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | |
0.000006 | - |
IC50: 6 nM | Homo sapiens | N-4-benzyloxybenzoyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | |
0.000006 | - |
IC50: 6 nM | Homo sapiens | N-(2-chlorophenyl)triazolyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | |
0.000009 | - |
IC50: 9 nM | Homo sapiens | N-(2,3-dichlorophenyl)triazolyl-L-leucine-(2-(4-methoxy)phenylaminoethyl)amide | |
0.000064 | - |
IC50: 64 nM | Oryctolagus cuniculus | Nalpha-4-methoxybenzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide | |
0.00047 | - |
IC50: 470 nM | Oryctolagus cuniculus | Nalpha-benzyloxycarbonyl-L-leucine(2-phenylaminoethyl)amide |